Benilde Bepouka Izizag1, Hippolyte Situakibanza1, Florian Kiazayawoko1, Aliocha Nkodila2, Eric Mafuta3, Philippe Lukanu4, Henry Mukumbi5, Murielle Longokolo1, Madone Mandina1, Nadine Mayasi1, Amede Kinuka6, Evelyne Amaela6, Willy Kazadi6, Marcel Mbula1. 1. Service des Maladies Infectieuses et Tropicales, Département de Médecine Interne, Cliniques Universitaires, Faculté de Médecine, Université de Kinshasa, Kinshasa, République Démocratique du Congo. 2. Cités des Aveugles, Kinshasa, République Démocratique du Congo. 3. Ecole de Santé Publique, Faculté de Médecine, Université de Kinshasa, Kinshasa, République Démocratique du Congo. 4. Département de Médecine de Famille, Université Protestante au Congo, Kinshasa, République Démocratique du Congo. 5. ACS AMO-CONGO (ONG-ASBL/Santé), Kinshasa, République Démocratique du Congo. 6. Cliniques Rapha, Kinshasa, République Démocratique du Congo.
Abstract
INTRODUCTION: the purpose of this study was to identify the determinants of non-compliance of persons living with HIV with antiretroviral treatment in Kinshasa. METHODS: we conducted a cross-sectional study in Kinshasa from 1st May to 31st August 2015. The study population was composed of patients aged at least 18 years living with HIV who had been treated with antiretroviral drugs for at least 3 months. Adherence Index (subjective method) and prescription refills (objective method) were used to assess compliance. Determinants of non-compliance were identified by logistic regression model. RESULTS: the 400 patients living with HIV had a median age of 43 years (18-75). Global non-compliance rate was 25.5%. Objective non-compliance rate was higher than that of subjective non-compliance (29% vs 21%, p = 0.01). Payment for consultation [adjusted odds ratio (AOR): 1.70; 95% confidence interval (95% CI): 1.02-2.81; p = 0.042), adverse reactions (AOR: 2.23; 95% CI: 1.33-3.75; p = 0.002) and the lack of awareness that missing a dose may worsen disease (AOR: 4.16; 95% CI: 1.04-16.68; p = 0.045) were determinants of non-compliance. Having trusted person was a protective factor versus non-compliance (AOR: 0.54; 95% CI: 0.39-0.93; p = 0.004). CONCLUSION: the rate of non-compliance with antiretroviral treatment is high in Kinshasa. The evaluation of determinants is necessary to establish strategies for improving compliance. Copyright: Benilde Bepouka Izizag et al.
INTRODUCTION: the purpose of this study was to identify the determinants of non-compliance of persons living with HIV with antiretroviral treatment in Kinshasa. METHODS: we conducted a cross-sectional study in Kinshasa from 1st May to 31st August 2015. The study population was composed of patients aged at least 18 years living with HIV who had been treated with antiretroviral drugs for at least 3 months. Adherence Index (subjective method) and prescription refills (objective method) were used to assess compliance. Determinants of non-compliance were identified by logistic regression model. RESULTS: the 400 patients living with HIV had a median age of 43 years (18-75). Global non-compliance rate was 25.5%. Objective non-compliance rate was higher than that of subjective non-compliance (29% vs 21%, p = 0.01). Payment for consultation [adjusted odds ratio (AOR): 1.70; 95% confidence interval (95% CI): 1.02-2.81; p = 0.042), adverse reactions (AOR: 2.23; 95% CI: 1.33-3.75; p = 0.002) and the lack of awareness that missing a dose may worsen disease (AOR: 4.16; 95% CI: 1.04-16.68; p = 0.045) were determinants of non-compliance. Having trusted person was a protective factor versus non-compliance (AOR: 0.54; 95% CI: 0.39-0.93; p = 0.004). CONCLUSION: the rate of non-compliance with antiretroviral treatment is high in Kinshasa. The evaluation of determinants is necessary to establish strategies for improving compliance. Copyright: Benilde Bepouka Izizag et al.
Authors: S B Mannheimer; R Mukherjee; L R Hirschhorn; J Dougherty; S A Celano; D Ciccarone; K K Graham; J E Mantell; L M Mundy; L Eldred; Michael Botsko; R Finkelstein Journal: AIDS Care Date: 2006-10
Authors: Carmen Ortego; Tania B Huedo-Medina; Javier Llorca; Lourdes Sevilla; Pilar Santos; Elías Rodríguez; Michelle R Warren; Javier Vejo Journal: AIDS Behav Date: 2011-10
Authors: Karina M Berg; Penelope A Demas; Andrea A Howard; Ellie E Schoenbaum; Marc N Gourevitch; Julia H Arnsten Journal: J Gen Intern Med Date: 2004-11 Impact factor: 5.128
Authors: April D Thames; Jennifer Moizel; Stella E Panos; Sapna M Patel; Desiree A Byrd; Hector F Myers; Gail E Wyatt; Charles H Hinkin Journal: AIDS Patient Care STDS Date: 2012-08-13 Impact factor: 5.078
Authors: Roger T Buju; Pierre Z Akilimali; Erick N Kamangu; Gauthier K Mesia; Jean Marie N Kayembe; Hippolyte N Situakibanza Journal: Int J Environ Res Public Health Date: 2022-01-19 Impact factor: 3.390
Authors: S Carlos; E Burgueño; A Ndarabu; G Reina; C Lopez-Del Burgo; A Osorio; B Makonda; J de Irala Journal: Sci Rep Date: 2021-03-08 Impact factor: 4.379